Bpifrance logo

Bpifrance

Europe, Ile-de-France, France, Maisons-alfort

Description

Bpifrance is the French public investment bank, established in 2012, playing a pivotal role in supporting the French economy. Its comprehensive mission spans from fostering innovation and providing financing for startups and SMEs to supporting mid-cap companies and large corporations in their growth, international expansion, and industrial projects. As a cornerstone of the French entrepreneurial ecosystem, Bpifrance offers a wide array of financial solutions, including equity investments, loans, guarantees, and export financing, aiming to address market failures and stimulate economic development across all sectors.

The bank's investment strategy is highly diversified, covering all stages of a company's lifecycle, from creation to IPO. In the realm of equity, Bpifrance is active across seed, venture, growth, and buyout capital. For early-stage companies, it provides direct equity investments and also acts as a significant limited partner in numerous private venture capital funds, thereby multiplying its impact. Its direct investments often target innovative deep tech companies and those aligned with national strategic priorities, such as green industries and industrial sovereignty.

Bpifrance's direct equity first cheques demonstrate a broad range, reflecting its diverse mandate. For seed-stage companies and early innovation projects, direct investments can start from approximately €100,000 (around $108,000 USD). As companies mature into venture and growth stages, Bpifrance's commitment can significantly increase. For instance, in growth equity rounds, typical first cheques can range from €5 million to upwards of €50 million (over $54 million USD), particularly for strategic national champions or companies with strong international potential. This flexibility allows Bpifrance to be a long-term partner, adapting its financial support as businesses scale.

Beyond equity, Bpifrance's impact is amplified through its extensive network and its role in mobilizing private capital. In 2023 alone, Bpifrance committed a remarkable €60 billion to support French businesses, underscoring its vast financial capacity and commitment to economic development. Its strategic focus on innovation, industrial re-localization, and ecological transition positions it as a key driver for France's future economic landscape, ensuring that companies have the necessary resources to innovate, grow, and compete globally.

Investor Profile

Bpifrance has backed more than 1,450 startups, with 136 new investments in the last 12 months alone. The firm has led 386 rounds, about 27% of its total and boasts 155 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in France, United States, Switzerland.
  • Strong thematic focus on Software, Biotechnology, Health Care.
  • Led 47 rounds in the past year.
  • Typical check size: $108K – $54M.

Stage Focus

  • Seed (24%)
  • Series Unknown (21%)
  • Series A (13%)
  • Series B (8%)
  • Grant (8%)
  • Debt Financing (7%)
  • Pre Seed (4%)
  • Private Equity (4%)
  • Series C (4%)
  • Post Ipo Equity (2%)

Country Focus

  • France (94%)
  • United States (3%)
  • Switzerland (1%)

Industry Focus

  • Software
  • Biotechnology
  • Health Care
  • Information Technology
  • Manufacturing
  • Artificial Intelligence (Ai)
  • Medical
  • Saas
  • Internet
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bpifrance frequently co-invest with?

Supernova Invest
Europe, Ile-de-France, France, Paris
Co-Investments: 33
Elaia
Europe, Ile-de-France, France, Paris
Co-Investments: 29
Partech
Europe, Ile-de-France, France, Paris
Co-Investments: 26
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 26
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 39
Eurazeo
Europe, Ile-de-France, France, Paris
Co-Investments: 50
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 41
BNP Paribas
Europe, Ile-de-France, France, Paris
Co-Investments: 50
Kima Ventures
Europe, Ile-de-France, France, Paris
Co-Investments: 49
Crédit Agricole
Europe, Ile-de-France, France, Montrouge
Co-Investments: 28

Which angels does Bpifrance often collaborate with?

DV
Europe, Ile-de-France, France, Paris
Shared Deals: 4
EL
North America, Florida, United States, Miami Beach
Shared Deals: 3
CC
Europe, Ile-de-France, France, Paris
Shared Deals: 3
XN
Europe, Ile-de-France, France, Paris
Shared Deals: 14
TE
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 10
RH
Europe, Ile-de-France, France, Paris
Shared Deals: 3
TP
Europe, Ile-de-France, France, Paris
Shared Deals: 4
ER
Europe, Ile-de-France, France, Paris
Shared Deals: 6
MB
Europe, Ile-de-France, France, Paris
Shared Deals: 4
DG
Europe, Ile-de-France, France, Paris
Shared Deals: 3

What are some of recent deals done by Bpifrance?

Electra

Paris, Ile-de-France, France

Electra is an electric vehicle charging company that specializes in deploying and operating charging points for electric vehicles.

AutomotiveCharging InfrastructureElectric VehicleRenewable Energy
Debt FinancingJul 24, 2025
Amount Raised: $332,660,176
AUSTRAL Dx

Paris, Ile-de-France, France

AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs.

ManufacturingMedicalMedical Device
GrantJul 24, 2025
MagREEsource

Grenoble, Rhone-Alpes, France

MagREEsource is to link the circular economy by providing a green metallurgical solution.

Mining
Series AJul 22, 2025
Amount Raised: $26,882,600
NFL Biosciences

Castelnau-le-lez, Languedoc-Roussillon, France

NFL Biosciences is a biotech which develops botanical drugs for the treatment of dependencies and addictions.

BiotechnologyMedicalPharmaceutical
Post Ipo DebtJul 22, 2025
Amount Raised: $1,402,570
Advicenne

Paris, Ile-de-France, France

Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases.

BiotechnologyMedicalPharmaceuticalTherapeutics
Post Ipo EquityJul 21, 2025
Amount Raised: $3,040,687
Aircap

Paris, Ile-de-France, France

Aircap is a digital platform that helps investors manage and oversee their investments, including portfolio companies and venture assets.

FinTechSaaS
SeedJul 21, 2025
Amount Raised: $581,464
Justclip

Clermont Herault, Languedoc-Roussillon, France

Justclip offers DIY electrical installation kits designed to make electrical work accessible to everyone, without technical skills.

CleanTechElectrical DistributionIndustrial Engineering
SeedJul 13, 2025
Amount Raised: $1,590,656
Solence

Paris, Ile-de-France, France

Solence offers a personalized digital app to support women with Polycystic Ovary Syndrome (PCOS).

AppsHealth CareHealth DiagnosticsWomen's
SeedJul 10, 2025
Amount Raised: $1,870,223
Hiqute Diamond

Boulogne-billancourt, Ile-de-France, France

Hiqute Diamond manufactures synthetic diamond plates for quantum tech and semiconductors.

Industrial EngineeringManufacturingSemiconductor
SeedJul 10, 2025
Amount Raised: $8,766,670
AFYREN

Saint-beauzire, Auvergne, France

AFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment.

Biotechnology
GrantJul 8, 2025
Amount Raised: $4,702,524